POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
PR Newswire•02/11/2026•16:05 ET
0
Key Highlights
- ➤POM (POM) fell below Nasdaq’s $50 million MVLS requirement for 30 consecutive business days
- ➤POM (POM) fell below Nasdaq’s $15 million MVPHS requirement for 30 consecutive business days
- ➤Nasdaq granted POM until April 26, 2027, to regain compliance with both requirements
- ➤Failure to regain compliance could subject POM securities to delisting, with appeal rights available
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements PR Newswire
GUANGZHOU, China, Nov. 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that on October 28, 2026, it received two letters (the "Letters") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") regarding deficiencies with respect to certain continued listing requirements of The Nasdaq Global Market.
Get started
Create a free account to read the full story.